SHANNON TODD: Open Payments
NPI 1881669224 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,134 in 74 payments from 5 companies in 2025. Trend: 2023 $86 · 2024 $609 · 2025 $31,134
Speaker / faculty: $17,730Travel & lodging: $8,950Food & beverage: $2,334Consulting: $2,120
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 31 | $13,306 |
| Ipsen Biopharmaceuticals, Inc | 30 | $12,806 |
| Gilead Sciences, Inc. | 11 | $4,784 |
| GENZYME CORPORATION | 1 | $125 |
| Boston Scientific Corporation | 1 | $113 |
Products named: REZDIFFRA, IQIRVO, Livdelzi, Bylvay, DUPIXENT, EXALT Model D.
Industry payments across MI — which companies pay providers there.
